Ruo Hua Cao
Director/Board Member bij SHANGHAI RENDU BIOTECHNOLOGY CO., LTD.
Profiel
Ruo Hua Cao is currently the Director at Shanghai Guo Chuang Pharmaceutical Co., Ltd.
and the Director & Deputy General Manager at Shanghai Rendu Biotechnology Co., Ltd.
Prior to her current positions, she obtained a graduate degree from The University of Chicago in 1992 and an undergraduate degree from National Taiwan University in 1988.
Actieve functies van Ruo Hua Cao
| Bedrijven | Functie | Begin |
|---|---|---|
| SHANGHAI RENDU BIOTECHNOLOGY CO., LTD. | Director/Board Member | - |
Shanghai Guo Chuang Pharmaceutical Co., Ltd.
 Shanghai Guo Chuang Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Guo Chuang Pharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of pharmaceutical products. Its products include pharmaceuticals against nervous system diseases, digestive system diseases, cardiovascular diseases, mental diseases, and immune system diseases. The company was founded on March 20, 2003 and is headquartered in Shanghai, China. | Director/Board Member | 01-12-2020 |
Opleiding van Ruo Hua Cao
| The University of Chicago | Graduate Degree |
| National Taiwan University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SHANGHAI RENDU BIOTECHNOLOGY CO., LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Shanghai Guo Chuang Pharmaceutical Co., Ltd.
Shanghai Guo Chuang Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Guo Chuang Pharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of pharmaceutical products. Its products include pharmaceuticals against nervous system diseases, digestive system diseases, cardiovascular diseases, mental diseases, and immune system diseases. The company was founded on March 20, 2003 and is headquartered in Shanghai, China. | Health Technology |
